Trails Edge Capital Partners, LP / IKT
Trails Edge Capital Partners, LP’s Inhibikase Therapeutics Inc Position
Does Trails Edge Capital Partners, LP own Inhibikase Therapeutics Inc (IKT)? Yes — 8.06M shares worth $14M (+3.10% of its 13F portfolio) as of Q1 2026, up from 6.18M shares the prior filed quarter.
Position Value
$14M
Q1 2026
Shares
8.06M
% of Portfolio
+3.10%
Quarters Held
2
currently held
Position History IKT
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of IKT.